Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany

被引：0
|
作者：
Klaus Krüger
Gerd Rüdiger Burmester
Siegfried Wassenberg
Matthias H. Thomas
机构：
[1] Rheumatologisches Praxiszentrum,Department of Rheumatology and Clinical Immunology
[2] Charité-Universitätsmedizin,Medical Affairs
[3] Rheumazentrum Ratingen,undefined
[4] MSD Sharp & Dohme GmbH,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Ankylosing spondylitis; First-line/second-line/third-line treatment; Golimumab; Noninterventional study; Psoriatic arthritis; Real-world evidence; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 382
页数：11
相关论文
共 50 条
  • [1] Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
    Krueger, Klaus
    Burmester, Gerd Ruediger
    Wassenberg, Siegfried
    Thomas, Matthias H.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 371 - 382
  • [2] Golimumab as First, Second or at Least Third Biologic Agent in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Post Hoc Analysis of a Non-Interventional Study in Germany
    Krueger, Klaus
    Burmester, Gerd
    Wassenberg, Siegfried
    Thiele, Astrid
    Thomas, Matthias
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] GOLIMUMAB AS FIRST, SECOND OR AT LEAST THIRD BIOLOGIC AGENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA) OR ANKYLOSING SPONDYLITIS (AS) - POST HOC ANALYSIS OF A NON-INTERVENTIONAL STUDY IN GERMANY
    Krueger, Klaus
    Burmester, Gerd Ruediger
    Wassenberg, Siegfried
    Thiele, Astrid
    Thomas, Matthias
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1156 - 1157
  • [4] Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Cantini, Fabrizio
    Niccoli, Laura
    Nannini, Carlotta
    Cassara, Emanuele
    Kaloudi, Olga
    Favalli, Ennio Giulio
    Becciolini, Andrea
    Benucci, Maurizio
    Gobbi, Francesca Li
    Guiducci, Serena
    Foti, Rosario
    Mosca, Marta
    Goletti, Delia
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (02) : 183 - 192
  • [5] Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis of a Non-Interventional Study in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Thiele, Astrid
    Thomas, Matthias H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] Golimumab in Biologic-NaiVe Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis from a Non-Interventional Evaluation in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] Non-Interventional Clinical Study Investigating the Use of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in Germany-3rd Interim Analysis
    Thomas, Matthias H.
    Krueger, Klaus
    Aries, Pee
    Bohl-Buehler, Martin
    Brandt-Juergens, Jan
    Rickert, Verena
    Wassenberg, Siegfried
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 131 - 140
  • [9] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
    Klaus Krüger
    Gerd R. Burmester
    Siegfried Wassenberg
    Martin Bohl-Bühler
    Matthias H. Thomas
    [J]. Rheumatology International, 2019, 39 : 131 - 140
  • [10] A NON-INTERVENTIONAL CLINICAL STUDY EVALUATING THE USE OF GOLIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA), PSORIATIC ARTHRITIS (PSA), AND ANKYLOSING SPONDYLITIS (AS) IN A REAL-LIFE SETTING IN GERMANY
    Krueger, K.
    Burmester, G. R.
    Wassenberg, S.
    Bohl-Buehler, M.
    Thomas, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 232 - 232
12345